Avalo Therapeutics, Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q1 2014 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Avalo Therapeutics, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2014 to Q2 2024.
  • Avalo Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was $98.5M.
  • Avalo Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2024 was -$36.2M, a 46.2% decline year-over-year.
  • Avalo Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$31.5M, a 24.3% increase from 2022.
  • Avalo Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$41.7M, a 50.6% increase from 2021.
  • Avalo Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$84.4M, a 32.9% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 -$36.2M $98.5M +$107M Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-12
Q1 2024 -$143M -$121M -$111M -1118% Jan 1, 2024 Mar 31, 2024 10-Q/A 2024-07-11
Q4 2023 -$31.5M -$8.17M +$1.64M +16.8% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-29
Q3 2023 -$33.2M -$5.23M -$8.42M -264% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 -$24.8M -$8.19M +$4.79M +36.9% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-12
Q1 2023 -$29.6M -$9.96M +$12.1M +54.9% Jan 1, 2023 Mar 31, 2023 10-Q/A 2024-07-11
Q4 2022 -$41.7M -$9.81M +$9.38M +48.9% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-29
Q3 2022 -$51M $3.19M +$20.6M Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 -$71.6M -$13M +$4.12M +24.1% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-03
Q1 2022 -$75.7M -$22.1M +$8.63M +28.1% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 -$84.4M -$19.2M -$3.55M -22.7% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-29
Q3 2021 -$80.8M -$17.4M -$3.94M -29.2% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-07
Q2 2021 -$76.9M -$17.1M -$3.82M -28.8% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 -$73.1M -$30.7M -$9.56M -45.3% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q4 2020 -$63.5M -$15.6M -$17.3M -1065% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-02
Q3 2020 -$46.2M -$13.5M -$9.44M -235% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 -$36.8M -$13.3M -$7.06M -113% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-02
Q1 2020 -$29.7M -$21.1M -$13.7M -183% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
Q4 2019 -$16.1M $1.62M +$7.18M Oct 1, 2019 Dec 31, 2019 10-K 2021-03-08
Q3 2019 -$23.3M -$4.02M +$20.6M +83.7% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 -$43.8M -$6.22M -$216K -3.59% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
Q1 2019 -$43.6M -$7.45M -$3.57M -92% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q4 2018 -$40.1M -$5.56M -$2.47M -79.8% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-11
Q3 2018 -$37.6M -$24.6M -$43.3M -231% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-14
Q2 2018 $5.74M -$6.01M -$4.21M -234% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-08
Q1 2018 $9.95M -$3.88M -$1.92M -98% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-09
Q4 2017 $11.9M -$3.09M -$1.45M -88.6% Oct 1, 2017 Dec 31, 2017 10-K 2018-04-02
Q3 2017 $13.3M $18.7M +$24.9M Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-13
Q2 2017 -$11.6M -$1.8M +$1.73M +49% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-09
Q1 2017 -$13.3M -$1.96M +$3.18M +61.9% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-11
Q4 2016 -$16.5M -$1.64M +$2.01M +55.1% Oct 1, 2016 Dec 31, 2016 10-K 2018-04-02
Q3 2016 -$18.5M -$6.17M -$5.48M -791% Jul 1, 2016 Sep 30, 2016 10-K 2018-04-02
Q2 2016 -$13M -$3.52M -$612K -21% Apr 1, 2016 Jun 30, 2016 10-K 2018-04-02
Q1 2016 -$12.4M -$5.14M -$1.9M -58.7% Jan 1, 2016 Mar 31, 2016 10-K 2018-04-02
Q4 2015 -$10.5M -$3.65M -$1.13M -44.6% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-14
Q3 2015 -$9.37M -$692K +$5.15M +88.2% Jul 1, 2015 Sep 30, 2015 10-K 2017-03-14
Q2 2015 -$14.5M -$2.91M +$1.15M +28.3% Apr 1, 2015 Jun 30, 2015 10-K 2017-03-14
Q1 2015 -$15.7M -$3.24M +$391K +10.8% Jan 1, 2015 Mar 31, 2015 10-K 2017-03-14
Q4 2014 -$16.1M -$2.52M Oct 1, 2014 Dec 31, 2014 10-K 2016-03-23
Q3 2014 -$5.84M Jul 1, 2014 Sep 30, 2014 10-K 2016-03-23
Q2 2014 -$4.06M Apr 1, 2014 Jun 30, 2014 10-K 2016-03-23
Q1 2014 -$3.63M Jan 1, 2014 Mar 31, 2014 10-K 2016-03-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.